Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Continuing healthcare services (including continuing care for children). This service is to supply assessment support services across CHC and Deprivation of Liberty Safeguards service areas. This includes reviews of patients, assessments of patients and support to appeals.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Carehome Selection Ltd (Trading as Xyla) | 03091598 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £949,999 initial term | 1 single bid — no competition | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
The contract end date was recorded incorrectly in the original published notice, sections II.2.4 and VI.3. The start and extension end dates were correct but end date given as 30/06/2025 instead of 2026.
As the correct start and extension end dates should have made it clear this was a typo the ICB do not anticipate extending the standstill period for this award as a result of this amendment.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C.
The contract award is confirmed following completion of the standstill period on 18/06/2025.
The contract award is for 1 July 2025 until 30 June 2026 with an optional 6 month extension until 31 December 2026.The anticipated maximum lifetime value of the contract is £1.14m (inc VAT).
No representations were received during the standstill period and there were no relevant conflicts of interest identified.